Keywords: Bayer, Natazia, Menstrual bleeding, EffRx Pharma, Binosto, Osteoporosis, USA, FDA

FDA approves Bayer HMB drug Natazia and EffRx osteo drug Binosto

Article | 15 March 2012

Print This

German drug major Bayer (BAY: DE) says its US subsidiary has received approval from the Food and Drug Administration of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in